文献速递耳科与耳神经

技术使用与听力干预效果:随机临床试验二次分析

Technology Use and Hearing Care Intervention Outcomes: A Secondary Analysis of a Randomized Clinical Trial.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2026-10-29

该研究基于HEARS随机临床试验的二次分析,纳入151名≥60岁未治疗听力损失且自报交流困难的老年人,评估基线技术使用是否改变社区健康工作者(CHW)提供的非处方(OTC)助听器干预对自我感知交流功能的效果。结果显示,技术连接组与未连接组的干预效果一致,组间差异为-1.6(95%CI -7.8至4.1)分。

要点

  • CHW提供的OTC助听器干预在技术连接与非连接老年人中均改善HHIE-S评分。
  • 基线技术使用未显著改变干预效果,组间差异无统计学意义。
  • 导航支持可能有助于缓解老年人听力干预中的技术障碍。

核心结论

  • CHW提供的听力干预效果在基线技术使用分层间一致,导航支持或可缓解技术相关障碍。

研究设计与样本

  • HEARS平行组1:1随机临床试验的二次事后亚组分析,2018年4月至2019年10月在巴尔的摩13个社区点招募≥60岁未治疗听力损失且自报交流困难者,纳入151人分析。

主要发现

  • 3个月时技术连接组HHIE-S评分平均下降14.1分(95%CI -17.6至-9.9),非连接组下降12.5分(95%CI -16.2至-5.2)。
  • 两组治疗效应估计差异为-1.6分(95%CI -7.8至4.1)。

关键数值与推荐

  • 技术连接定义为近期使用智能手机、电脑或平板、互联网、电子邮件或短信。
  • 主要结局为随机化后3个月HHIE-S评分较基线的变化。

临床怎么用

  • 对老年人提供OTC助听器干预时,无论其基线技术使用如何,均可考虑CHW导航支持。

局限性

  • 为二次事后亚组分析,样本量151人,探索性发现需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Over-the-counter (OTC) hearing aids often rely on digital technologies that may limit access for older adults with low technology use. Community health worker (CHW)-delivered interventions may help overcome these barriers, but it is unclear whether baseline technology usage modifies intervention efficacy. OBJECTIVE: To evaluate whether an older adult's baseline technology use modifies the effect of a CHW-delivered hearing care intervention incorporating OTC hearing devices on self-perceived communication function. DESIGN, SETTING, AND PARTICIPANTS: This secondary post hoc subgroup analysis used data from the HEARS (Hearing Health Equity Through Accessible Research & Solutions) study, a parallel-group 1:1 randomized clinical trial with waitlist controls that was conducted between April 2018 and October 2019. HEARS recruited older adults (age ≥ 60 years) with untreated hearing loss and self-reported communication difficulties from 13 community sites, including affordable independent housing complexes and senior centers, in Baltimore, Maryland. The primary end point was assessed at 3 months postrandomization, with additional descriptive follow-up through 12 months postintervention. Data were analyzed from August 2023 to March 2026. INTERVENTION: A CHW-delivered hearing care intervention that includes the provision of a low-cost OTC hearing device, device orientation, and navigational support or a wait-list control. MAIN OUTCOMES AND MEASURES: Change from baseline score on the Hearing Handicap Inventory for the Elderly-Screening Version (HHIE-S) at 3 months postrandomization was the primary outcome. Participants were classified as technology-connected if they reported recent use of a smartphone, computer or tablet, the internet, or email or text messaging. Intervention effects were estimated using doubly robust weighted least squares, stratified by technology use. RESULTS: The analysis comprised 151 participants (mean [SD] age, 76.7 [8.0] years; 101 females [67.8%]), of whom 108 (71.5%) were technology-connected. At 3 months postrandomization, HHIE-S scores decreased by a mean of 14.1 (95% CI, -17.6 to -9.9) points among technology-connected participants and by 12.5 (95% CI, -16.2 to -5.2) points among not-connected participants compared with their respective controls. The estimated difference in treatment effect between groups was -1.6 (95% CI, -7.8 to 4.1) points.. CONCLUSIONS AND RELEVANCE: This secondary analysis of a randomized clinical trial found that the estimated treatment effects of a CHW-delivered hearing care intervention were consistent across strata of participants' baseline technology use. These exploratory findings suggest that navigational support may mitigate technology-related barriers in hearing care interventions for older adults. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03442296.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Wang, Betz, Garcia Morales, et al. Technology Use and Hearing Care Intervention Outcomes: A Secondary Analysis of a Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg. 2026. PMID: 42954970. doi:10.1001/jamaoto.2026.3331

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。